Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Farhad Fakhrejahani, MD

LICENSE # 0101262331
 
Issue Date: 4/25/2017
Expiration Date: 9/30/2024
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 7/31/2022
None Reported
Academic Appointments - Non-US
Last Updated 7/31/2022
None Reported
Publications
(up to ten in the last five years)
Last Updated 7/31/2022
The role of consolidation treatment in locally advanced unresectable NSCLC.
Curr Oncol Rep.
Volume: 15
Date: 08 2013

Radiation exposure from diagnostic procedures following allogeneic stem cell transplantation--how much is acceptable?
Hematology
Volume: 19
Date: 07 2014

Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation.
Biol Blood Marrow Transplant.
Volume: 20
Date: 07 2014

Stomach GIST presenting as a liver abscess.
J Gastrointest Cancer.
45 Suppl
Date: 12 2014

Immunotherapies for bladder cancer: a new hope.
Curr Opin Urol.
Volume: 25
Date: 11 2015

The use of gene expression profiling and mutation analysis increases the cost of care for patients with carcinoma of unknown primary; does it also improve survival?
Eur J Cancer
Volume: 54
Date: 02 2016

Management Options for Biochemically Recurrent Prostate Cancer.
Curr Treat Options Oncol.
Volume: 18
Date: 05 2017